SMJ International Holdings Inc. Announced Closing of $10 Million Initial Public Offering (NYSE: SMJF)
SINGAPORE – (BUSINESSWIRE) – SMJ International Holdings Inc. (“SMJ” or the “Company”), a Singapore-based premium flooring specialist that distributes a wide range of premier flooring products under its proprietary “SMJ” brand across Asia markets, announced the closing its initial public offering (the “Offering”) of an aggregate 2,500,000 Class A ordinary shares par value US$0.0002 per share at a price of US$4.00 per share to the public (the “Offering Price”), for a total of US$10,000,000 of gross proceeds to the Company, before deducting underwriting discounts and other offering expenses.
Citius Oncology, Inc. Announces Closing of $9 Million Registered Direct Offering and Concurrent Private Placement (Nasdaq: CTOR)
CRANFORD, N.J., Sept. 10, 2025 /PRNewswire/ – Citius Oncology, Inc. (“Citius Oncology”) (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. (“Citius Pharma”) (Nasdaq: CTXR), a late-stage biopharmaceutical company developing and commercializing first-in-class critical care products, announced the closing of its previously announced registered direct offering and concurrent private placement of an aggregate of 5,142,858 shares of common stock and unregistered warrants to purchase up to an aggregate of 5,142,858 shares of common stock. The combined effective offering price for each share of common stock and accompanying warrant was $1.75. The warrants have an exercise price of $1.84 per share, will be exercisable six months from the date of issuance, and will expire on the five and one-half year anniversary from the date of issuance.
Curanex Pharmaceuticals Inc. Announces Closing of $15 Million Initial Public Offering (Nasdaq: CURX)
Curanex Pharmaceuticals Inc. (Nasdaq: CURX) (“Curanex” or the “Company”), a developmental stage pharmaceutical company focused on discovering and developing botanical drugs for inflammatory diseases, today announced the closing of its initial public offering (the “Offering”) of 3,750,000 shares of common stock at a public offering price of $4.00 per share, for gross proceeds of $15 million, before deducting underwriting discounts and offering expenses. The Offering was conducted on a firm commitment basis. The Company’s shares of common stock began trading on the Nasdaq Capital Market on August 26, 2025 under the ticker symbol “CURX.”